
The drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 40 mg in the US market, the latest Enforcement Report by the USFDA said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39gNhCJ
via
IFTTT
0 comments:
Post a Comment